Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tardoxal for Tardive Dyskinesia (TEND-TD)
NCT00917293Phase 2Terminated
- Sponsor
- Medicure Inc.
- Start
- May 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Tardoxal in tardive dyskinesia (TD), sponsored by Medicure Inc.. Started May 2009; status: terminated.
02
Drugs
Tardoxal
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT00917293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917293.